Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide offerings.

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

The FDA warned that several hundred units of counterfeit 1-mg semaglutide (Ozempic) were found in the U.S. drug supply chain ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron, its ...

Two common GLP-1 medications that are approved by the Food and Drug Administration (FDA) specifically for weight loss are ...

The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza.

Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

Insurance companies face a growing challenge as they adapt to the rise of GLP-1 receptor agonists, such as Ozempic and Wegovy ...

During the time period 2020 to 2023, approximately 1 in 5 youth and 1 in 3 adults with type 1 diabetes and severe obesity ...

Nestlé unveils science-backed protein drinks to help manage hunger, support muscle health and aid weight loss for GLP-1 users ...